Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 2900837)

Published in Eur Neuropsychopharmacol on November 06, 2008

Authors

Francesco Leri1, Yan Zhou, Benjamin Goddard, AnneMarie Levy, Derek Jacklin, Mary Jeanne Kreek

Author Affiliations

1: Department of Psychology, University of Guelph, Guelph, Canada. fleri@uoguelph.ca

Articles citing this

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest (2012) 1.26

The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res (2009) 1.25

Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. Brain Res (2009) 1.01

Opioid-dopamine interactions: implications for substance use disorders and their treatment. Biol Psychiatry (2010) 0.82

Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats. Physiol Behav (2014) 0.80

Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat. J Addict Res Ther (2011) 0.80

Identification of substance use and dependence among patients with viral hepatitis. Dig Liver Dis (2010) 0.78

β-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving. Neuropsychopharmacology (2013) 0.78

Conditioned stimuli's role in relapse: preclinical research on Pavlovian-Instrumental-Transfer. Psychopharmacology (Berl) (2016) 0.77

Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression. Eur Neuropsychopharmacol (2011) 0.76

Fructose:glucose ratios--a study of sugar self-administration and associated neural and physiological responses in the rat. Nutrients (2015) 0.76

Effects of Venlafaxine & Methadone Alone and in Combination with Spontaneous Morphine withdrawal Syndrome & Pain Sensation in Rats. Basic Clin Neurosci (2015) 0.75

Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonment. Ann N Y Acad Sci (2011) 0.75

Nitric oxide and histone deacetylases modulate cocaine-induced mu-opioid receptor levels in PC12 cells. BMC Pharmacol Toxicol (2012) 0.75

The opioid receptors as targets for drug abuse medication. Br J Pharmacol (2015) 0.75

The effects of acute and chronic steady state methadone on memory retrieval in rats. Psychopharmacology (Berl) (2012) 0.75

Articles cited by this

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32

Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci (2001) 6.86

Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75

Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08

Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci (2006) 5.69

From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol (1980) 5.46

A role for lateral hypothalamic orexin neurons in reward seeking. Nature (2005) 5.41

A role for brain stress systems in addiction. Neuron (2008) 4.71

Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci (1992) 4.57

Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron (2006) 4.39

Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23

Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol (2007) 3.11

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A (2005) 3.05

Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci (2006) 2.84

Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science (1996) 2.68

Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience (1991) 2.58

Afferents to the orexin neurons of the rat brain. J Comp Neurol (2006) 2.57

The hypocretins: setting the arousal threshold. Nat Rev Neurosci (2002) 2.42

Pharmacotherapy of addictions. Nat Rev Drug Discov (2002) 2.31

On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience (1992) 2.23

Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev (1995) 2.17

A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2002) 2.08

Opioids block long-term potentiation of inhibitory synapses. Nature (2007) 1.94

Cocaine-associated stimuli increase cocaine seeking and activate accumbens core neurons after abstinence. J Neurosci (2007) 1.91

Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem (2002) 1.90

Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci (2003) 1.89

Orexin (hypocretin) neurons contain dynorphin. J Neurosci (2001) 1.84

Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther (1995) 1.73

Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sci (2003) 1.65

The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend (1995) 1.65

The role of reward pathways in the development of drug dependence. Pharmacol Ther (1987) 1.62

Predicting cocaine use among methadone patients: analysis of findings from a national study. Hosp Community Psychiatry (1992) 1.61

Conditioned reinforcing properties of stimuli paired with self-administered cocaine, heroin or sucrose: implications for the persistence of addictive behaviour. Neuropharmacology (2004) 1.59

Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J Chem Neuroanat (1995) 1.56

Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry (2008) 1.53

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med (1996) 1.51

Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry (2005) 1.48

Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry (2005) 1.41

Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature (1981) 1.37

Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. J Addict Dis (2007) 1.34

Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol (2006) 1.34

'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res (1993) 1.32

Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend (1995) 1.27

Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology (2002) 1.23

d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther (1999) 1.18

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett (1995) 1.17

Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res (1992) 1.17

PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry (2005) 1.15

Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine. Behav Neurosci (2001) 1.12

The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett (1997) 1.12

Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem Pharmacol (1998) 1.11

Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol (2008) 1.06

Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience (2008) 1.01

High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis (2006) 0.99

Effects of chronic methadone treatment on cocaine- and food-maintained responding under second-order, progressive-ratio and concurrent-choice schedules in rhesus monkeys. Drug Alcohol Depend (2004) 0.99

Opioid modulation of ventral pallidal inputs. Ann N Y Acad Sci (1999) 0.98

Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis (1992) 0.97

Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain. Neuropsychopharmacology (2005) 0.97

Extinction of cocaine-induced place approach in rats: a validation of the "biased" conditioning procedure. Brain Res Bull (1993) 0.97

Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci (1999) 0.97

Retracted Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. J Neurosci (2006) 0.96

Methadone maintenance reduces heroin- and cocaine-induced relapse without affecting stress-induced relapse in a rodent model of poly-drug use. Neuropsychopharmacology (2004) 0.96

Orexin, drugs and motivated behaviors. Nat Neurosci (2005) 0.96

Cocaine, dopamine and the endogenous opioid system. J Addict Dis (1996) 0.96

In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. Mol Pharmacol (2003) 0.95

Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse (1986) 0.95

Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Brain Res Mol Brain Res (1992) 0.94

Regulation of opioid receptors by cocaine. Ann N Y Acad Sci (2001) 0.92

A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat. Psychopharmacology (Berl) (2007) 0.91

Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: are the combinations better reinforcers? Psychopharmacology (Berl) (2001) 0.90

Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Ther (1996) 0.90

Continuous cocaine administration enhances mu- but not delta-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens. Eur J Pharmacol (1996) 0.89

Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum. Anat Rec A Discov Mol Cell Evol Biol (2004) 0.88

D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience (1995) 0.88

Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol (1998) 0.87

Effects of chronic buprenorphine treatment on levels of nucleus accumbens glutamate and on the expression of cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl) (2008) 0.85

Opioidergic modulation of cocaine conditioned place preferences. Life Sci (1992) 0.85

Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice. Synapse (2002) 0.85

Cocaine abuse sharply reduced in an effective methadone maintenance program. J Addict Dis (1999) 0.84

Reinstatement of conditioned reinforcing properties of cocaine-conditioned stimuli. Pharmacol Biochem Behav (2006) 0.84

Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. J Pharmacol Exp Ther (1995) 0.83

Contingency does not contribute to the effects of cocaine self-administration on prodynorphin and proenkephalin gene expression in the rat forebrain. Brain Res (2006) 0.82

Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system. Pol J Pharmacol (2003) 0.80

Dopamine affects basal and augmented pituitary hormone secretion. J Clin Endocrinol Metab (1978) 0.80

Cocaine-induced changes in gene expression in rat brain. NIDA Res Monogr (1990) 0.79

WHO 60th Anniversary Commemorative Volume. Bull World Health Organ (2008) 0.78

High-dose methadone maintenance in rats: effects on cocaine self-administration and behavioral side effects. Neuropsychopharmacology (2007) 0.78

Articles by these authors

The diploid genome sequence of an Asian individual. Nature (2008) 46.29

A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell (2006) 10.10

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet (2003) 4.41

Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry (2007) 4.37

Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res (2005) 3.79

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) (2002) 3.74

Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry (2006) 3.55

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med (2008) 3.28

Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol (2003) 3.22

The HBV drug entecavir - effects on HIV-1 replication and resistance. N Engl J Med (2007) 3.20

The phosphothreonine lyase activity of a bacterial type III effector family. Science (2007) 3.18

Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol (2004) 3.13

Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest (2004) 2.95

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J Virol (2002) 2.89

Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J Virol (2003) 2.78

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest (2009) 2.75

Complete resequencing of 40 genomes reveals domestication events and genes in silkworm (Bombyx). Science (2009) 2.68

The multifactorial nature of HIV-1 latency. Trends Mol Med (2004) 2.68

Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol (2010) 2.33

Lithium diaqua-magnesium catena-borodiphosphate(V) monohydrate, LiMg(H(2)O)(2)[BP(2)O(8)]·H(2)O, at 173 K. Acta Crystallogr Sect E Struct Rep Online (2008) 2.28

Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) (2003) 2.27

The analysis of large-scale gene expression correlated to the phase changes of the migratory locust. Proc Natl Acad Sci U S A (2004) 2.26

Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem (2003) 2.19

Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog (2006) 2.08

An empirical assessment of long-branch attraction artefacts in deep eukaryotic phylogenomics. Syst Biol (2005) 2.02

Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology (Berl) (2004) 2.02

Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry (2011) 2.01

Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun (2005) 1.98

Characterization of a novicida-like subspecies of Francisella tularensis isolated in Australia. J Med Microbiol (2003) 1.97

Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective. Drug Alcohol Depend (2012) 1.88

Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest (2006) 1.88

Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood (2008) 1.86

Heterotachy and long-branch attraction in phylogenetics. BMC Evol Biol (2005) 1.86

Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol (2007) 1.84

Latency in human immunodeficiency virus type 1 infection: no easy answers. J Virol (2003) 1.83

Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations. Cancer Prev Res (Phila) (2010) 1.80

Lineage specification and plasticity in CD19- early B cell precursors. J Exp Med (2006) 1.80

The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem (2007) 1.78

K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res (2011) 1.72

Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol (2008) 1.71

Laboratory analysis of tularemia in wild-trapped, commercially traded prairie dogs, Texas, 2002. Emerg Infect Dis (2004) 1.70

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology (2005) 1.66

Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues. Psychoneuroendocrinology (2005) 1.66

Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Sci Signal (2010) 1.64

Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem (2005) 1.64

Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis (2014) 1.59

Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury. Hepatology (2003) 1.59

Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry (2004) 1.56

Something of value: the introduction of contingency management interventions into the New York City Health and Hospital Addiction Treatment Service. J Subst Abuse Treat (2005) 1.52

High-performance, all-solution-processed organic nanowire transistor arrays with inkjet-printing patterned electrodes. Langmuir (2011) 1.52

Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature (2011) 1.50

Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis. Synapse (2003) 1.50

Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population. Int J Cancer (2010) 1.49

Carbon dioxide-induced anesthesia results in a rapid increase in plasma levels of vasopressin. Endocrinology (2009) 1.49

The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend (2003) 1.48

Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. J Biol Chem (2011) 1.48

A Legionella type IV effector activates the NF-kappaB pathway by phosphorylating the IkappaB family of inhibitors. Proc Natl Acad Sci U S A (2009) 1.48

A pair of allelic WRKY genes play opposite roles in rice-bacteria interactions. Plant Physiol (2009) 1.47

Evaluation of GO-based functional similarity measures using S. cerevisiae protein interaction and expression profile data. BMC Bioinformatics (2008) 1.47

SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol (2007) 1.47

Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology (Berl) (2005) 1.43

Reactivity to laboratory stress provocation predicts relapse to cocaine. Drug Alcohol Depend (2009) 1.42

Genome sequence of the insect pathogenic fungus Cordyceps militaris, a valued traditional Chinese medicine. Genome Biol (2011) 1.42

Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res (2009) 1.42

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest (2009) 1.39

Permanent Genetic Resources added to Molecular Ecology Resources Database 1 August 2009-30 September 2009. Mol Ecol Resour (2010) 1.39

Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A (2011) 1.36

Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol (2007) 1.36

Structural mechanism of host Rab1 activation by the bifunctional Legionella type IV effector SidM/DrrA. Proc Natl Acad Sci U S A (2010) 1.35

A role for the clock gene per1 in prostate cancer. Cancer Res (2009) 1.35

Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol (2006) 1.34

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? Neuropsychopharmacology (2005) 1.34

Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res (2013) 1.33

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet (2008) 1.33

A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. J Virol (2005) 1.32

Abnormal white matter integrity in adolescents with internet addiction disorder: a tract-based spatial statistics study. PLoS One (2012) 1.32

Complete genomic characterization of a pathogenic A.II strain of Francisella tularensis subspecies tularensis. PLoS One (2007) 1.31

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat (2010) 1.31

Haploinsufficiency of the mouse Forkhead Box f1 gene causes defects in gall bladder development. J Biol Chem (2002) 1.30

κ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. Trends Neurosci (2012) 1.29

Chemical profiling of Radix Paeoniae evaluated by ultra-performance liquid chromatography/photo-diode-array/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal (2008) 1.29

The genome of the hydatid tapeworm Echinococcus granulosus. Nat Genet (2013) 1.29

Progression of subclinical coronary atherosclerosis: does obesity make a difference? Circulation (2005) 1.27

Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics. J Clin Invest (2012) 1.26

Human cytotrophoblasts acquire aneuploidies as they differentiate to an invasive phenotype. Dev Biol (2005) 1.25

Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction (2007) 1.24

Genome biology of Actinobacillus pleuropneumoniae JL03, an isolate of serotype 3 prevalent in China. PLoS One (2008) 1.23

Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology (2008) 1.23

Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology (2008) 1.23

Genetic control of a transition from black to straw-white seed hull in rice domestication. Plant Physiol (2011) 1.22

Microarray studies of psychostimulant-induced changes in gene expression. Addict Biol (2005) 1.22

PB2 and hemagglutinin mutations are major determinants of host range and virulence in mouse-adapted influenza A virus. J Virol (2010) 1.21